Share This

Public company info - Venus Medtech (Hangzhou) Inc.- H share , 02500.HK

Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Venus Medtech (Hangzhou) Inc.- H share, 02500.HK - Cash Flow 2019-12 2018-12 2017-12
Net Cash Flow from Operating Activities -302,164 -151,467 -82,266
Net Cash Flow from Return on Investments & Servicing of Finance -5,102 -3,094 -1,510
 Interest Received 3,876 0 0
 Interest Paid -8,978 -3,094 -1,510
 Dividend Received 0 0 0
 Dividend Paid 0 0 0
 Others 0 0 0
Taxes (Paid) / Refunded -5,003 0 0
Net Cash Flow from Investing Activities -30,969 -194,146 -46,993
 Additions to Fixed Assets -15,709 -14,991 -7,526
 Disposal of Fixed Assets 3 50 0
 Increase in Investments -6,443 -192,547 -23,474
 Decrease in Investments 0 13,100 28
 Net Cash Flow with Related Parties 308,900 445,294 145,895
 Others -317,720 -445,052 -161,916
Net Cash Flow before Financing Activities -343,238 -348,707 -130,769
Net Cash Flow from Financing Activities 2,586,333 456,261 174,478
 New Loans 120,000 80,000 30,000
 Loans Repayment -87,691 -62,386 -1,417
 Fixed Income/Debt Instruments 0 0 0
 Repayment of Fixed Income/Debt Instruments 0 0 0
 Equity Financing 2,523,928 0 0
 Net Cash Flow with Related Parties 308,900 445,294 145,895
 Others -278,804 -6,647 0
Increase(Decrease) in Cash & Cash Equivalents 2,243,095 107,554 43,709
Cash & Cash Equivalents at Beginning of Year 164,914 59,015 13,437
Net Cash Flow due to Change in Exchange Rate/Others 5,245 -1,655 1,869
Cash & Cash Equivalents at End of Year 2,413,254 164,914 59,015
Currency Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.